HUP0302585A3 - Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions - Google Patents

Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions

Info

Publication number
HUP0302585A3
HUP0302585A3 HU0302585A HUP0302585A HUP0302585A3 HU P0302585 A3 HUP0302585 A3 HU P0302585A3 HU 0302585 A HU0302585 A HU 0302585A HU P0302585 A HUP0302585 A HU P0302585A HU P0302585 A3 HUP0302585 A3 HU P0302585A3
Authority
HU
Hungary
Prior art keywords
allerreactions
tendency
develop
individual
reducing
Prior art date
Application number
HU0302585A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of HUP0302585A2 publication Critical patent/HUP0302585A2/hu
Publication of HUP0302585A3 publication Critical patent/HUP0302585A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/202—Genetic engineering of microorganisms used in dairy technology
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
HU0302585A 2000-09-25 2001-09-21 Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions HUP0302585A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00120867 2000-09-25
PCT/EP2001/010956 WO2002024883A2 (en) 2000-09-25 2001-09-21 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions

Publications (2)

Publication Number Publication Date
HUP0302585A2 HUP0302585A2 (hu) 2003-10-28
HUP0302585A3 true HUP0302585A3 (en) 2007-05-02

Family

ID=8169939

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302585A HUP0302585A3 (en) 2000-09-25 2001-09-21 Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions

Country Status (21)

Country Link
US (1) US7498162B2 (hu)
EP (1) EP1379635A2 (hu)
JP (1) JP2004514424A (hu)
KR (1) KR20030034178A (hu)
CN (1) CN1246456C (hu)
AR (1) AR033574A1 (hu)
AU (2) AU2056102A (hu)
BG (1) BG107657A (hu)
BR (1) BR0114105A (hu)
CA (1) CA2420160A1 (hu)
CZ (1) CZ2003749A3 (hu)
HU (1) HUP0302585A3 (hu)
IL (1) IL154284A0 (hu)
MX (1) MXPA03001673A (hu)
NO (1) NO20031159L (hu)
NZ (1) NZ524527A (hu)
PL (1) PL365246A1 (hu)
RU (1) RU2294366C2 (hu)
SK (1) SK3642003A3 (hu)
WO (1) WO2002024883A2 (hu)
ZA (1) ZA200301244B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
AU2003236156A1 (en) * 2003-04-24 2005-01-04 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1824973A1 (en) * 2004-12-14 2007-08-29 Alk-Abello A/S Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2003989A1 (en) * 2006-03-31 2008-12-24 DSMIP Assets B.V. Process for the hydrolysis of milk proteins
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
DK2391222T3 (da) * 2009-01-27 2014-10-06 Arla Foods Amba Mælk med lang holdbarhed og mælke-relaterede produkter samt fremgangsmåde og mælkebehandlingsanlæg til deres fremstilling
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP3097791B1 (en) * 2010-06-04 2018-05-16 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2751573B1 (en) * 2011-09-02 2017-11-08 DH Technologies Development Pte. Ltd. System and method for the detection of ovalbumin
WO2013083140A1 (en) 2011-12-07 2013-06-13 N.V. Nutricia Beta-lactoglobulin peptides for treating cow's milk protein allergy
WO2016148562A1 (en) * 2015-03-18 2016-09-22 N.V. Nutricia Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic
CN105362296A (zh) * 2015-11-27 2016-03-02 成都吉氧屋科技有限公司 乳酸菌洗鼻液
WO2019212330A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with a specific beta-lactoglobulin peptide
WO2019212329A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides
US20230101980A1 (en) * 2019-05-16 2023-03-30 Trillitye PAULLIN Method, system and apparatus for substance identification
CN114149486B (zh) * 2021-05-28 2023-05-12 中国科学院大连化学物理研究所 一种抗菌肽mamp-01及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302855D0 (sv) * 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
US5817308A (en) * 1994-02-14 1998-10-06 University Of Rochester Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
WO1996032486A1 (en) * 1995-04-11 1996-10-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
GB9518323D0 (en) 1995-09-07 1995-11-08 Steidler Lothar Materials and methods relating to the attachment and display of substances on cell surfaces
RU2170023C2 (ru) * 1997-12-25 2001-07-10 Петров Леонид Николаевич Штамм lactobacillus acidophilus а-91, используемый для приготовления кисломолочных продуктов, штамм lactobacillus acidophilus h-91, используемый для приготовления кисломолочных продуктов, закваска для приготовления кисломолочных продуктов и препарат, способствующий адаптации организма к неблагоприятным внешним воздействиям
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
MY129566A (en) * 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance

Also Published As

Publication number Publication date
NO20031159D0 (no) 2003-03-13
IL154284A0 (en) 2003-09-17
CZ2003749A3 (cs) 2003-06-18
MXPA03001673A (es) 2003-06-09
WO2002024883A3 (en) 2003-11-06
AU2056102A (en) 2002-04-02
JP2004514424A (ja) 2004-05-20
KR20030034178A (ko) 2003-05-01
CN1246456C (zh) 2006-03-22
BR0114105A (pt) 2003-07-29
EP1379635A2 (en) 2004-01-14
SK3642003A3 (en) 2003-08-05
ZA200301244B (en) 2004-05-14
US20040071714A1 (en) 2004-04-15
AR033574A1 (es) 2003-12-26
CA2420160A1 (en) 2002-03-28
PL365246A1 (en) 2004-12-27
NO20031159L (no) 2003-05-20
AU2002220561C1 (en) 2002-04-02
RU2294366C2 (ru) 2007-02-27
AU2002220561B2 (en) 2007-01-11
CN1479788A (zh) 2004-03-03
BG107657A (bg) 2003-12-31
HUP0302585A2 (hu) 2003-10-28
NZ524527A (en) 2005-05-27
US7498162B2 (en) 2009-03-03
WO2002024883A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
HUP0302585A3 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions
AU2058702A (en) Use of probiotic lactic acid bacteria for balancing the skin's immune system
SI1371647T1 (en) Pyridine-3-carboxylic acid derivatives and their use as intermediates
HUP0101854A3 (en) The use of fumaric acid derivatives in transplant medicine
AU6692701A (en) 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
HUP0900587A3 (en) Stable salts of 3,3-diphenylpropylamines and preparation thereof
IL145078A0 (en) Lactic acid bacteria strains capable of preventing diarrhoea
HUP0203029A3 (en) Oral form of administration containing probiotic micro-organisms
HUP0300025A3 (en) Somnogenic activity of non-pathogenic lactic acid bacteria
IL134410A0 (en) Novel lactic acid bacteria
GB9807464D0 (en) Purification of human acid µ-glucosidase
GB2365444B (en) Novel lactic acid bacterial preparation having biopurification activity
GB9904804D0 (en) Identification of bacteria
PL364171A1 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
GB0011186D0 (en) Modification of bacteria
HUP0301059A3 (en) Use of lactic acid bacterium for the treatment of peritonitis
AP2002002483A0 (en) Lactic acid bacteria for the treatment and/or prophylaxix of giardasis
AU4415501A (en) Regulation of human gelatinase b-like enzyme 1
GB9826352D0 (en) Use of novel molecule to promote bacterial growth
AU9080098A (en) Resistance mechanisms to ic type r/m bacteriophages of lactic acid bacteria
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2003224361A1 (en) Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees